Teva to host R&D Day for investors, analysts

Teva will host an R&D Day in New York on Nov. 11, 2026, outlining its pipeline and five-year value-creation priorities. Presentations are scheduled for 8:30 a.m. to 12:30 p.m. ET. * In-person attendance will be invitation-only due to limited capacity. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva Pharmaceutical Industries Ltd. published the original content used to generate this news brief via (Ref. ID: 202610121745PRIMZONEFULLFEED1001277605) on October 12, 2026, and is solely responsible for the information contained therein. (C)